Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011457 |
---|---|
Receipt number | R000013413 |
Scientific Title | Phase II trial of induction mFOLFOX6 plus Avastin followed by neoaduvant chemoradiotherapy with TS-1 for MRI-defined high-risk rectal cancer (IMPACT-RC) |
Date of disclosure of the study information | 2013/08/11 |
Last modified on | 2019/07/08 15:27:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/08/11 23:11:30 | ||
2 | Update | 2014/03/11 10:16:49 | Target sample size |
|
3 | Update | 2015/03/11 09:34:38 | TEL Last name of contact person Last name of contact person TEL |
|
4 | Update | 2015/09/11 09:18:29 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2015/09/11 09:19:09 | Target sample size |
|
6 | Update | 2015/09/23 02:03:38 | Target sample size |
|
7 | Update | 2015/09/23 02:08:30 | Other related information Other related information |
|
8 | Update | 2015/09/23 02:10:57 | Other related information |
|
9 | Update | 2018/02/15 00:25:40 | Recruitment status Publication of results |
|
10 | Update | 2019/07/08 15:22:39 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Organization Organization Address Address Tel |
|
11 | Update | 2019/07/08 15:23:35 | Number of participants that the trial has enrolled |
|
12 | Update | 2019/07/08 15:27:50 | Recruitment status Date of IRB Last follow-up date |